Literature DB >> 14969496

Exact log-rank tests for unequal follow-up.

Georg Heinze1, Michael Gnant, Michael Schemper.   

Abstract

The asymptotic log-rank and generalized Wilcoxon tests are the standard procedures for comparing samples of possibly censored survival times. For comparison of samples of very different sizes, an exact test is available that is based on a complete permutation of log-rank or Wilcoxon scores. While the asymptotic tests do not keep their nominal sizes if sample sizes differ substantially, the exact complete permutation test requires equal follow-up of the samples. Therefore, we have developed and present two new exact tests also suitable for unequal follow-up. The first of these is an exact analogue of the asymptotic log-rank test and conditions on observed risk sets, whereas the second approach permutes survival times while conditioning on the realized follow-up in each group. In an empirical study, we compare the new procedures with the asymptotic log-rank test, the exact complete permutation test, and an earlier proposed approach that equalizes the follow-up distributions using artificial censoring. Results confirm highly satisfactory performance of the exact procedure conditioning on realized follow-up, particularly in case of unequal follow-up. The advantage of this test over other options of analysis is finally exemplified in the analysis of a breast cancer study.

Entities:  

Mesh:

Year:  2003        PMID: 14969496     DOI: 10.1111/j.0006-341x.2003.00132.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

Authors:  Rui Wang; Stephen W Lagakos; Robert J Gray
Journal:  Biostatistics       Date:  2010-05-02       Impact factor: 5.899

2.  Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.

Authors:  Summit Sawhney; Aldo J Montano-Loza; Peter Salat; Mairin McCarthy; Norman Kneteman; Judith Meza-Junco; Richard Owen
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

3.  Sizing clinical trials when comparing bivariate time-to-event outcomes.

Authors:  Tomoyuki Sugimoto; Toshimitsu Hamasaki; Scott R Evans; Takashi Sozu
Journal:  Stat Med       Date:  2017-01-24       Impact factor: 2.373

4.  Weighted logrank tests for interval censored data when assessment times depend on treatment.

Authors:  Michael P Fay; Joanna H Shih
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

5.  Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.

Authors:  Gottfried Novacek; Wolfgang Miehsler; Julia Palkovits; Walter Reinisch; Thomas Waldhör; Stylianos Kapiotis; Alfred Gangl; Harald Vogelsang
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

6.  MONET: Multi-omic module discovery by omic selection.

Authors:  Nimrod Rappoport; Roy Safra; Ron Shamir
Journal:  PLoS Comput Biol       Date:  2020-09-15       Impact factor: 4.475

7.  Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.

Authors:  Jorge E Cortes; H Jean Khoury; Hagop Kantarjian; Tim H Brümmendorf; Michael J Mauro; Ewa Matczak; Dmitri Pavlov; Jean M Aguiar; Kolette D Fly; Svetoslav Dimitrov; Eric Leip; Mark Shapiro; Jeff H Lipton; Jean-Bernard Durand; Carlo Gambacorti-Passerini
Journal:  Am J Hematol       Date:  2016-04-13       Impact factor: 10.047

8.  A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.

Authors:  Peng He; Frank Eriksson; Thomas H Scheike; Mei-Jie Zhang
Journal:  Scand Stat Theory Appl       Date:  2015-06-05       Impact factor: 1.396

9.  Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.

Authors:  Michael P Fay; Pamela A Shaw
Journal:  J Stat Softw       Date:  2010-08       Impact factor: 6.440

10.  Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Authors:  Cody S Nelson; Diana Vera Cruz; Dollnovan Tran; Kristy M Bialas; Lisa Stamper; Huali Wu; Margaret Gilbert; Robert Blair; Xavier Alvarez; Hannah Itell; Meng Chen; Ashlesha Deshpande; Flavia Chiuppesi; Felix Wussow; Don J Diamond; Nathan Vandergrift; Mark R Walter; Peter A Barry; Michael Cohen-Wolkowiez; Katia Koelle; Amitinder Kaur; Sallie R Permar
Journal:  JCI Insight       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.